There is a current chemotherapy drug available that is extremely successful in treating anaggressive form of breast cancer. This drug has as a serious side effect in that 20% of the recipients will subsequently go on to develop ALL, an often untreatable and fatal form of leukemia. The pharmaceutical company is developing a modified version of this drug and long term clinical trials are being conducted on 214 women afflicted with this aggressive form of breast cancer. The trials have indicated 31 subsequent cases of ALL. State and test the hypothesis that there is no difference in the proportion of ALL cases between the two chemotherapy drugs against the alternative that there is a difference. Set alpha equal to 0.02
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here